Medtech Leaders


Medtech Leaders Agenda

Day One | Day Two

Tuesday, June 21 -Medtech Leaders
(All times in EDT)


9:15am Chair’s opening remarks


9:25am Capitalising on MedTech opportunities post Covid: the current upsurge and necessity of innovation, product development and business opportunities across MedTech and how it is changing the investment landscape

During the pandemic years there has been a scarcity of MedTech deals and with backlog of MedTech procedures due an increase 2022 following the deferral of non-emergency procedures, 2022 is set for a hype of activity. A panel of MedTech companies and stakeholders involved in recent mergers or acquisitions discuss:

  • The challenges and drivers of the current M&A landscape
  • Has innovation across product design led to new collaborations and deals from MedTech leaders
  • What are the most significant challenges MedTech innovators encounter on the way to acquisition—where are the crucial inflection points in the journey?
  • How has trend towards more large consolidations impacted innovators ready to be acquired?

Richard Wilmot, Head of Philips Venture Investments, Phillips
Christopher Cleary, VP Corporate Development, Medtronic
Laura Niklason, CEO, Humacyte
Townsend Goddard
, Senior VP of Global Business Development, Olympus

Richard Wilmot, Head, Philips Health Tech Ventures    Christopher Cleary, VP Corporate Development, Medtronic    Laura Niklason, CEO, Humacyte    Shadow 300x


10:05am Successful partnering with MedTech Leaders and Providers: navigating commercial success by securing the right partner at the right time

The healthcare infrastructure is under considerable strain which has resulted in changes in solution requirements and budgets. Healthcare providers are seeking cost effective and easy-to-implementation products from the MedTech sector. As well as new digital and supportive services. This panel will discuss how MedTech leaders are not only positioning themselves to deliver the healthcare provision but also making strategic partnerships to streamline the process. Hear what MedTech solutions are crucial to US healthcare systems and learn what opportunities leading medical devices players are looking for emerging MedTech companies to bring to the table.

Antonio Sanchez-Cordero, VP Business Development (M&A) Peripheral Intervention, BD
Julian Nikolchev, Senior VP Corporate Development & Strategy, Intuitive Surgical
Tariq Arif
, Business Development Officer, UCLA Technology Development Group


Antonio Sanchez-Cordero, VP Business Development (M&A) Peripheral Intervention, BD    Julian Nikolchev, Senior VP Corporate Development & Strategy, Intuitive    Tariq Arif, Business Development Officer, UCLA Technology Development Group


10:45am Coffee break and refreshments


11:15am Investing in all MedTech: forensic review the investment interests, landscape, opportunities across medical devices, connected medical products and digital services

MedTech is ripe for growth following the increasing globally revenue of over $500 billion annually and need for patient centric products in healthcare due to the pandemic in recent years. It has new business opportunities particularly in digital products and robotics, but with more established companies reaping the investments and market access regulatory legislation for new players unclear, where and why are investors placing their bets for this growing market.

Oliver Keown, Director, Intuitive Ventures
Debbie Lin, Executive in Residence, DigitalDx
Lori Hu, Managing Director, Vertex Ventures
Jeffrey Schwartz
, Managing Director, Bain Capital

Oliver Keown, Managing Director, Intuitive Ventures    Debbie Lin, Executive Director, Boehringer Ingelheim Venture Fund    Lori Hu, Managing Director, Vertex Ventures    Jeffrey Schwartz, Managing Director, Bain Capital


11:55pm The Digital Age of MedTech

Digital innovation has seen vast growth across healthcare particularly in MedTech, where digital and data solutions can be applied to many medical devices’ verticals including diagnostics and surgical equipment. A panel of experts will discuss digital innovation, investment and adoption across the MedTech industry:

  • How can you utilise digital solutions to make patient centric products in MedTech
  • Consideration of digital adoption and timelines and while taking full advantage of market growth potential
  • What investment practices are backing the integration of digital and data within MedTech
  • Addressing the gaps in medical devices with digital offerings, how can traditional medical devices and digital connected medical devices evolve together

Diana Saraceni, Managing Partner, Panakès Partners
Deanna Harshbarger, VP Product, Cala Health
Thomas Hummel, Digital Transformation Corporate Development, Fresenius Kabi
Abhinav Shashank
, Co-Founder and Chief Executive, Innovaccer

Diana Saraceni, Partner, Panakès Partners    Deanna Harshbarger, VP Product, Cala Health    Thomas Hummel, Head of Strategy & Innovation, Siemens Healthineers    Abhinav Shashank, Co-Founder and Chief Executive, Innovaccer


12:35pm Value based Healthcare expansion with Real World Evidence/Data

There is continued pressure from payers on MedTech players importance of demonstrating capabilities through RWE/RWD and so the importance of value-based health care approach to provide patient centric products and improved market share. A panel of experts will discuss the creation and expansion opportunities of value-based healthcare within the MedTech:

  • How is market growing around RWE/RWD and impacting Value based Healthcare within MedTech
  • Necessity of improved data accumulation and clinical trial management
  • The opportunity and requirement new funding and payment models, and markets parallel with healthcare for medical devices

Wolfgang Mueller, Global Healthcare Transformation Initiative Lead, Roche Diagnostics
Ramita Tandon, Chief Clinical Trials Officer, Walgreens Boots Alliance
Lynda Brown-Ganzert
, Chief Executive Officer, Curatio
Cory Wiegert
, COO, IntegraConnect
Claire Woodthorpe
, VP Europe, Chief Operating Officer, Light Point Medical

Wolfgang Mueller, Roche Diagnostics Healthcare Transformation Initiative Lead, Roche Diagnostics    Ramita Tandon, Chief Clinical Trials Officer, Walgreens Health    Lynda Brown-Ganzert, Chief Executive Officer, Curatio   Cory Wiegert, COO, IntegraConnect   Claire Woodthorpe, VP, Europe & COO, Lightpoint Medical


1:15pm Lunch


2:15pm MedTech Partnering Presentation

BD


2:30pm MedTech Partnering Presentation

Intuitive Surgical


2:45pm MedTech Partnering Presentation

Medtronic


3:00pm MedTech Partnering Presentation

Philips


3:15pm Coffee break and refreshments


4:00pm Regulation and risk reduction without a pre-market approval: designing smart clinical design, market need to de-risk development and achieve breakthrough designation

  • Regulatory oversights and the challenges with new products within medical devices and diagnostics
  • Building pre-clinical and trial data to get PMA or breakthrough designations
  • How to de-risk product development to secure scaling investment

Kathy Lee-Sepsick, President & Chief Executive Officer, Femasys

Kathy Lee-Sepsick, President & Chief Executive Officer, Femasys


4:30pm Panel: Mapping MedTech Market Access: Understanding the dynamics between provider, patient and product for market entry

Point of care and patient centric products has always been at the heart of healthcare. Now increasing so, not only is the patient, as the end user, looking to be more involved in their healthcare, but the healthcare systems in the US are also looking for patients to adopt more MedTech innovations to relieve some of the pressures traditional systems within hospitals. But in practise how easily are these solutions being implemented and how are MedTech players working with providers to play the right the market access strategy, secured pricing and reimbursement infrastructure.

Understanding how the adoption journey differs depending on geographical market
Navigating local and national market access routes to benefit providers, payers and patients

Bob Bargenquast, Head of U.S. Market Access Strategy & Reimbursement, Zeiss
Shani Noel
, Director, Market Access & Managed Care, Respiratory Health, Baxter
Rebecca Decker
, Head of Global Health Economics and Market Access, Siemens Healthineers

Bob Bargenquast, Head of U.S. Market Access Strategy & Reimbursement, Zeiss    Shani Noel, Director, Market Access & Managed Care, Respiratory Health, Baxter    Rebecca Decker, Head of Global Health Economics and Market Access, Siemens Healthineers


5:20pm Close of Day 1


5:30pm Networking Drinks Reception

The networking drinks reception takes place Tuesday, June 21. Attendees can look forward to a fantastic night of networking and double down on their event relationship building.

 

Wednesday, June 22 - Break out sessions
(All times in EDT)


9:15am MedTech CEO Forum

LSX Medtech CEO Forum

Open to CEO, Founder, Co-Founder, President, Chairman or or c-suite executives (CFO, CBO, CCO, CSO, CMO) of US and Medtech companies.

Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants. 

Please sign-up during registration.

Find out more

DOWNLOAD BROCHURE